Xilio Therapeutics Inc
Change company Symbol lookup
Select an option...
XLO Xilio Therapeutics Inc
ORN Orion Group Holdings Inc
SMHI SEACOR Marine Holdings Inc
ASC Ardmore Shipping Corp
CCBC Chino Commercial Bancorp
INGR Ingredion Inc
PROF Profound Medical Corp
VWAGY Volkswagen AG
MLVF Malvern Bancorp Inc
GBCI Glacier Bancorp Inc
Go

Company profile

Xilio Therapeutics, Inc. is a biotechnology company. The Company is focused on harnessing the immune system to achieve clinical responses for cancer patients. It offers a geographically precise solutions (GPS) platform to engineer molecules, including cytokines and other biologics, that are designed to enhance therapeutic index. Using its GPS platform, the Company is engaged in developing a pipeline of tumor-selective cytokine and checkpoint inhibitor immunotherapies to treat cancer. Its product candidates include XTX101, XTX202, XTX301, and XTX401. XTX101 is a clinical-stage, tumor-selective anti-cytotoxic T-lymphocyte-associated protein (CTLA-4), monoclonal antibody (mAb), which is designed to improve upon the therapeutic index of existing anti-CTLA-4 therapies. XTX202 and XTX301 are an engineered form of interleukin 2 (IL-2) that is masked with a protein domain to prevent binding activity until the protein domain is cleaved off by tumor microenvironment (TME)-associated proteases.

Closing Price
$2.39
Day's Change
-0.01 (-0.42%)
Bid
--
Ask
--
B/A Size
--
Day's High
2.60
Day's Low
2.17
Volume
(Heavy Day)
Volume:
816,733

10-day average volume:
173,568
816,733

Citigroup Inc. Stock Falls Tuesday, Still Outperforms Market

4:42 pm ET April 26, 2022 (MarketWatch)
Print

This article was automatically generated by MarketWatch using technology from Automated Insights.

Shares of Citigroup Inc. (C) shed 1.76% to $50.23 Tuesday, on what proved to be an all-around poor trading session for the stock market, with the S&P 500 Index falling 2.81% to 4,175.20 and Dow Jones Industrial Average falling 2.38% to 33,240.18. This was the stock's fourth consecutive day of losses. Citigroup Inc. closed $30.06 short of its 52-week high ($80.29), which the company achieved on June 2nd.

Despite its losses, the stock outperformed some of its competitors Tuesday, as JPMorgan Chase & Co. (JPM) fell 2.96% to $123.02, Bank of America Corp. (BAC) fell 2.25% to $36.45, and Wells Fargo & Co. (WFC) fell 2.73% to $44.58.true Trading volume (17.8 M) remained 10.7 million below its 50-day average volume of 28.5 M.

Data source: Dow Jones Market Data, FactSet. Data compiled April 26, 2022.

-MarketWatch Automation

	

(END) Dow Jones Newswires

April 26, 2022 16:42 ET (20:42 GMT)

Copyright (c) 2022 Dow Jones & Company, Inc.

Earnings Calendar and Events Data provided by |Terms of Use| © 2022 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

Information and news provided by ,, , Computrade Systems, Inc., ,, and

Copyright © 2022. All rights reserved.